Home  »  Business   »  Wall Street Praises Minerva Surgical Inc. (UTRS) A...

Wall Street Praises Minerva Surgical Inc. (UTRS) After Recent Earnings Report

Minerva Surgical Inc. (NASDAQ:UTRS) went down by -5.95% from its latest closing price compared to the recent 1-year high of $7.59. The company’s stock price has collected -17.93% of loss in the last five trading sessions.

Is It Worth Investing in Minerva Surgical Inc. (NASDAQ :UTRS) Right Now?

The average price from analysts is $5.00, which is $4.82 above the current price. UTRS currently public float of 26.84M and currently shorts hold a 0.56% ratio of that float. Today, the average trading volume of UTRS was 151.38K shares.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


UTRS’s Market Performance

UTRS stocks went down by -17.93% for the week, with a monthly drop of -51.77% and a quarterly performance of -90.35%, while its annual performance rate touched -97.46%. The volatility ratio for the week stands at 20.86% while the volatility levels for the past 30 days are set at 21.47% for Minerva Surgical Inc. The simple moving average for the period of the last 20 days is -42.20% for UTRS stocks with a simple moving average of -92.91% for the last 200 days.

Analysts’ Opinion of UTRS

Many brokerage firms have already submitted their reports for UTRS stocks, with UBS repeating the rating for UTRS by listing it as a “Buy.” The predicted price for UTRS in the upcoming period, according to UBS is $15 based on the research report published on November 16th of the previous year 2021.

SVB Leerink, on the other hand, stated in their research note that they expect to see UTRS reach a price target of $17. The rating they have provided for UTRS stocks is “Outperform” according to the report published on November 16th, 2021.

Piper Sandler gave a rating of “Overweight” to UTRS, setting the target price at $17 in the report published on November 16th of the previous year.

UTRS Trading at -68.17% from the 50-Day Moving Average

After a stumble in the market that brought UTRS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.65% of loss for the given period.

Volatility was left at 21.47%, however, over the last 30 days, the volatility rate increased by 20.86%, as shares sank -54.23% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -87.25% lower at present.

During the last 5 trading sessions, UTRS fell by -17.93%, which changed the moving average for the period of 200-days by -96.55% in comparison to the 20-day moving average, which settled at $0.2982. In addition, Minerva Surgical Inc. saw -96.53% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at UTRS starting from Clapper David M, who purchase 25,000 shares at the price of $4.94 back on Dec 13. After this action, Clapper David M now owns 642,660 shares of Minerva Surgical Inc., valued at $123,435 using the latest closing price.